Literature DB >> 25582623

Glucose-dependent insulinotropic polypeptide (GIP) directly affects collagen fibril diameter and collagen cross-linking in osteoblast cultures.

Aleksandra Mieczkowska1, Beatrice Bouvard2, Daniel Chappard3, Guillaume Mabilleau4.   

Abstract

Glucose-dependent insulinotropic polypeptide (GIP) is absolutely crucial in order to obtain optimal bone strength and collagen quality. However, as the GIPR is expressed in several tissues other than bone, it is difficult to ascertain whether the observed modifications of collagen maturity, reported in animal studies, were due to direct effects on osteoblasts or indirect through regulation of signals originating from other tissues. The aims of the present study were to investigate whether GIP can directly affect collagen biosynthesis and processing in osteoblast cultures and to decipher which molecular pathways were necessary for such effects. MC3T3-E1 cells were cultured in the presence of GIP ranged between 10 and 100pM. Collagen fibril diameter was investigated by electron microscopy whilst collagen maturity was determined by Fourier transform infra-red microspectroscopy (FTIRM). GIP treatment resulted in dose-dependent increases in lysyl oxidase activity and collagen maturity. Furthermore, GIP treatment shifted the collagen fiber diameter towards lower value but did not significantly affect collagen heterogeneity. GIP acted directly on osteoblasts by activating the adenylyl cyclase-cAMP pathway. This study provides evidences that GIP acts directly on osteoblasts and is capable of improving collagen maturity and fibril diameter.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Collagen; GIP; Osteoblast

Mesh:

Substances:

Year:  2015        PMID: 25582623     DOI: 10.1016/j.bone.2015.01.003

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  6 in total

Review 1.  Diabetes pharmacotherapy and effects on the musculoskeletal system.

Authors:  Evangelia Kalaitzoglou; John L Fowlkes; Iuliana Popescu; Kathryn M Thrailkill
Journal:  Diabetes Metab Res Rev       Date:  2018-12-20       Impact factor: 4.876

Review 2.  Gut Hormones and Their Effect on Bone Metabolism. Potential Drug Therapies in Future Osteoporosis Treatment.

Authors:  Sine Paasch Schiellerup; Kirsa Skov-Jeppesen; Johanne Agerlin Windeløv; Maria Saur Svane; Jens Juul Holst; Bolette Hartmann; Mette Marie Rosenkilde
Journal:  Front Endocrinol (Lausanne)       Date:  2019-02-26       Impact factor: 5.555

3.  Impaired Gastric Hormone Regulation of Osteoblasts and Lysyl Oxidase Drives Bone Disease in Diabetes Mellitus.

Authors:  Eileen J Daley; Paola Divieti Pajevic; Sayon Roy; Philip C Trackman
Journal:  JBMR Plus       Date:  2019-08-07

4.  β-Catenin mediates glucose-dependent insulinotropic polypeptide increases in lysyl oxidase expression in osteoblasts.

Authors:  Eileen J Daley; Philip C Trackman
Journal:  Bone Rep       Date:  2021-04-13

5.  [Gly²]-GLP-2, But Not Glucagon or [D-Ala²]-GLP-1, Controls Collagen Crosslinking in Murine Osteoblast Cultures.

Authors:  Aleksandra Mieczkowska; Beatrice Bouvard; Erick Legrand; Guillaume Mabilleau
Journal:  Front Endocrinol (Lausanne)       Date:  2021-08-04       Impact factor: 5.555

6.  Impacts of Glucose-Dependent Insulinotropic Polypeptide on Orthodontic Tooth Movement-Induced Bone Remodeling.

Authors:  Taisuke Yamauchi; Megumi Miyabe; Nobuhisa Nakamura; Mizuho Ito; Takeo Sekiya; Saki Kanada; Rina Hoshino; Tatsuaki Matsubara; Ken Miyazawa; Shigemi Goto; Keiko Naruse
Journal:  Int J Mol Sci       Date:  2022-08-10       Impact factor: 6.208

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.